生殖医学杂志

参考文献

[1] Balen AH,Morley LC,Misso M,et al.The management of anovulatory infertility in women with polycystic ovary syndrome:an analysis of the evidence to support the development of global WHO guidance[J].Hum Reprod Update,2016,22:687-708.

[2] Zhang J,Bao Y,Zhou X,et al.Polycystic ovary syndrome and mitochondrial dysfunction[J].Reprod Biol Endocrinol,2019,17:67.

[3] Kempegowda P,Melson E,Manolopoulos KN,et al.Implicating androgen excess in propagating metabolic disease in polycystic ovary syndrome[J].Ther Adv Endocrinol Metab,2020,11:2042018820934319.

[4] Lazúrová I,Lazúrová Z,Figurová J,et al.Relationship between steroid hormones and metabolic profile in women with polycystic ovary syndrome[J].Physiol Res,2019,68:457-465.

[5] 郑美荣，麦建爱，林尧明，等.多囊卵巢综合征患者血清性激素水平与胰岛素抵抗的相关性分析[J].临床医学研究与实践，2021,6:97-99.

[6] 李东晓，张尧，张宏武，等.高同型半胱氨酸血症的诊断、治疗与预防专家共识[J].罕少疾病杂志，2022,29:1-4.

[7] Chakraborty P,Mitra I,Kalapahar S,et al.Significance of hyperhomocysteinemia in immediate as well as long-term health risk/s in women with polycystic ovary syndrome:a probabilistic model using dynamic bayesian network analysis[J].Reprod Sci,2023,30:1207-1216.

[8] Kucuk T,Horozal PE,Karakulak A,et al.Follicular homocysteine as a marker of oocyte quality in PCOS and the role of micronutrients[J].J Assist Reprod Genet,2023,40:1933-1941.

[9] Zeng X,Xie YJ,Liu YT,et al.Polycystic ovarian syndrome:correlation between hyperandrogenism,insulin resistance and obesity[J].Clin Chim Acta,2020,502:214-221.

[10] Calzada M,López N,Noguera JA,et al.Elevation of isoprostanes in polycystic ovary syndrome and its relationship with cardiovascular risk factors[J].J Endocrinol Invest,2019,42:75-83.

[11] Shang Y,Zhou H,Hu M,et al.Effect of diet on insulin resistance in polycystic ovary syndrome[J].J Clin Endocrinol Metab,2020,105:dgaa425.

[12] 罗蓉，王宇，缪阿风，等.正常体质指数的多囊卵巢综合征患者发生胰岛素抵抗的影响因素研究[J].中国全科医学，2023,26:2102-2107.

[13] 吴亚妹，马宁，黄兹宝，等.胰岛素抵抗影响多囊卵巢综合征发病及机制的研究进展[J].生殖医学杂志，2021,30:1247-1251.

[14] Li D,Liu HX,Fang YY,et al.Hyperhomocysteinemia in polycystic ovary syndrome:decreased betaine-homocysteine methyltransferase and cystathionine β-synthase-mediated homocysteine metabolism[J/OL].Reprod Biomed Online,2018,37:234-241.

[15] Qi X,Zhang B,Zhao Y,et al.Hyperhomocysteinemia promotes insulin resistance and adipose tissue inflammation in PCOS mice through modulating M2 macrophage polarization via estrogen suppression[J].Endocrinology,2017,158:1181-1193.

[16] Kayac?k G?,?zdemir Erdoan M,Pehlivan A,et al.The effect of metformin treatment on leukocyte telomere length in patients with polycystic ovary syndrome:a prospective case-control study[J].J Assist Reprod Genet,2022,39:2153-2161.

[17] Liao B,Qi X,Yun C,et al.Effects of androgen excess-related metabolic disturbances on granulosa cell function and follicular development[J].Front Endocrinol(Lausanne),2022,13:815968.

[18] Bhushan R,Sinha P.Correlation of serum homocysteine levels and hyperinsulinaemia with body mass index in polycystic ovarian syndrome[J].J Hum Reprod Sci,2022,15:34-41.

[19] Li T,Wu RJ,Liang QQ,et al.Analysis of serum homocysteine concentration in patients less than 35 years of age with polycystic ovary syndrome and hyperandrogenism[J].Ginekol Pol,2023,94:518-523.

[20] 于佳瑞，常惠，陈京京，等.同型半胱氨酸在多囊卵巢综合征中的研究进展[J].生殖医学杂志，2020,29:125-129.

[21] 陈丽，郝丽娟.多囊卵巢综合征患者腹型肥胖、高雄、胰岛素抵抗及脂代谢的相关性分析[J].医学信息，2022,35:113-117.

[22] Liu C,Liu L,Wang Y,et al.Hyperhomocysteinemia increases risk of metabolic syndrome and cardiovascular death in an elderly Chinese community population of a 7-year follow-up study[J].Front Cardiovasc Med,2021,8:811670.

[23] Wang J,You D,Wang H,et al.Association between homocysteine and obesity:a meta-analysis[J].J Evid Based Med,2021,14:208-217.

[24] Yuan S,Mason AM,Carter P,et al.Homocysteine,B vitamins,and cardiovascular disease:a mendelian randomization study[J].BMC Med,2021,19:97.

[25] Alesi S,Ee C,Moran LJ,et al.Nutritional supplements and complementary therapies in polycystic ovary syndrome[J].Adv Nutr,2022,13:1243-1266.

[26] Feng W,Zhang Y,Pan Y,et al.Association of three missense mutations in the homocysteine-related MTHFR and MTRR gene with risk of polycystic ovary syndrome in southern Chinese women[J].Reprod Biol Endocrinol,2021,19:5.

[27] 冯婉琴，潘沅，张懿，等.MTHFR和MTRR基因多态性与多囊卵巢综合征的相关性研究[J].现代妇产科进展，2020,29:825-829.

[28] Razi Y,Eftekhar M,Fesahat F,et al.Concentrations of homocysteine in follicular fluid and embryo quality and oocyte maturity in infertile women:a prospective cohort[J].J Obstet Gynaecol,2021,41:588-593.

[29] Liu S,Mo M,Xiao S,et al.Pregnancy outcomes of women with polycystic ovary syndrome for the first in vitro fertilization treatment:a retrospective cohort study with 7678 patients[J].Front Endocrinol(Lausanne),2020,11:575337.

[30] 赵铭佳，吴剑华，李翠，等.同型半胱氨酸对卵子质量及体外受精妊娠结局的影响[J].中国妇幼保健，2017,32:4476-4479.

[31] Khan MJ,Ullah A,Basit S.Genetic basis of polycystic ovary syndrome(PCOS):current perspectives[J].Appl Clin Genet,2019,12:249-260.

[32] Lessey BA,Young SL.What exactly is endometrial receptivity?[J].Fertil Steril,2019,111:611-617.

[33] 仇嘉昕，高玉平.子宫内膜容受性判断新进展[J].生殖医学杂志，2019,28:965-969.

[34] Yang X,Tian X,Liu H,et al.Homocysteine increases uterine artery blood flow resistance in women with pregnancy loss[J].J Gynecol Obstet Hum Reprod,2023,52:102533.

[35] Hu L,Ma L,Xia X,et al.Efficacy of bariatric surgery in the treatment of women with obesity and polycystic ovary syndrome[J].J Clin Endocrinol Metab,2022,107:e3217-e3229.

[36] Fu Y,Wang X,Kong W.Hyperhomocysteinaemia and vascular injury:advances in mechanisms and drug targets[J].Br J Pharmacol,2018,175:1173-1189.

[37] Duic F,Dnil CA,Boboc AE,et al.Impact of increased oxidative stress on cardiovascular diseases in women with polycystic ovary syndrome[J].Front Endocrinol(Lausanne),2021,12:614679.

[38] Dai C,Fei Y,Li J,et al.A novel review of homocysteine and pregnancy complications[J].Biomed Res Int,2021,2021:6652231.

[39] D’Souza SW,Glazier JD.Homocysteine metabolism in pregnancy and developmental impacts[J].Front Cell Dev Biol,2022,10:802285.

[40] 王丽，吕淑兰，毛文军，等.多囊卵巢综合征患者子宫内膜容受性和妊娠率分析[J].山西医科大学学报，2020,51:577-581.